aclacinomycin has been researched along with Carcinoma, Oat Cell in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Homma, T; Min, KY; Nakagawa, H; Yoneda, S; Yoshida, S | 1 |
Coley, HM; Twentyman, PR; Workman, P | 2 |
3 other study(ies) available for aclacinomycin and Carcinoma, Oat Cell
Article | Year |
---|---|
[Aclacinomycin; benefits for the treatment of malignant pleural effusion].
Topics: Aclarubicin; Adenocarcinoma; Aged; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Naphthacenes; Pleural Effusion; Rabbits | 1983 |
Further examination of 9-alkyl- and sugar-modified anthracyclines in the circumvention of multidrug resistance.
Topics: Aclarubicin; Animals; Carcinoma, Small Cell; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Structure-Activity Relationship; Tumor Cells, Cultured | 1992 |
9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistance.
Topics: Aclarubicin; Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Doxorubicin; Drug Resistance; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Mice; Neoplasm Proteins; Tumor Cells, Cultured | 1990 |